Stevens Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-516
Closed -$215K 128
2022
Q3
$215K Buy
+516
New +$215K 0.14% 123
2022
Q2
Sell
-835
Closed -$470K 136
2022
Q1
$470K Buy
835
+497
+147% +$280K 0.1% 172
2021
Q4
$255K Buy
+338
New +$255K 0.06% 217
2019
Q4
Sell
-1,744
Closed -$580K 606
2019
Q3
$580K Sell
1,744
-14,341
-89% -$4.77M 0.05% 326
2019
Q2
$5.03M Buy
16,085
+2,859
+22% +$894K 0.22% 134
2019
Q1
$4.04M Buy
13,226
+9,595
+264% +$2.93M 0.17% 163
2018
Q4
$843K Sell
3,631
-13,262
-79% -$3.08M 0.04% 410
2018
Q3
$5.29M Buy
16,893
+6,505
+63% +$2.04M 0.19% 150
2018
Q2
$3M Buy
10,388
+2,733
+36% +$788K 0.11% 222
2018
Q1
$1.91M Buy
7,655
+1,795
+31% +$449K 0.07% 299
2017
Q4
$1.4M Buy
+5,860
New +$1.4M 0.05% 364
2017
Q3
Sell
-3,272
Closed -$740K 852
2017
Q2
$740K Sell
3,272
-11,259
-77% -$2.55M 0.03% 494
2017
Q1
$2.9M Buy
14,531
+7,602
+110% +$1.52M 0.11% 252
2016
Q4
$1.26M Buy
6,929
+4,345
+168% +$792K 0.05% 391
2016
Q3
$423K Buy
+2,584
New +$423K 0.02% 603
2016
Q1
Sell
-14,379
Closed -$1.99M 895
2015
Q4
$1.99M Buy
14,379
+8,803
+158% +$1.22M 0.08% 284
2015
Q3
$749K Buy
5,576
+3,172
+132% +$426K 0.03% 421
2015
Q2
$362K Sell
2,404
-4,490
-65% -$676K 0.01% 695
2015
Q1
$932K Buy
6,894
+1,092
+19% +$148K 0.03% 429
2014
Q4
$699K Buy
5,802
+1,050
+22% +$126K 0.02% 499
2014
Q3
$539K Buy
+4,752
New +$539K 0.02% 572
2013
Q4
Sell
-9,582
Closed -$1.13M 1014
2013
Q3
$1.13M Buy
9,582
+3,030
+46% +$356K 0.03% 460
2013
Q2
$735K Buy
+6,552
New +$735K 0.02% 499